These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26448478)

  • 1. The inferior impact of antibody-mediated rejection on the clinical outcome of kidney allografts that develop de novo thrombotic microangiopathy.
    Wu K; Budde K; Schmidt D; Neumayer HH; Lehner L; Bamoulid J; Rudolph B
    Clin Transplant; 2016 Feb; 30(2):105-17. PubMed ID: 26448478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol Biopsies in Patients With Subclinical De Novo Donor-specific Antibodies After Kidney Transplantation: A Multicentric Study.
    Bertrand D; Gatault P; Jauréguy M; Garrouste C; Sayegh J; Bouvier N; Caillard S; Lanfranco L; Galinier A; Laurent C; Etienne I; Farce F; François A; Guerrot D
    Transplantation; 2020 Aug; 104(8):1726-1737. PubMed ID: 32732853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Early Thrombotic Microangiopathy in Renal Transplantation.
    Mour GK; Ninan J; Butterfield D; Zhang N; Nair SS; Smith M; Ryan M; Reddy K; Heilman RL
    Clin Transplant; 2024 Jul; 38(7):e15373. PubMed ID: 39023085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients.
    Koppula S; Yost SE; Sussman A; Bracamonte ER; Kaplan B
    Clin Transplant; 2013; 27(4):591-7. PubMed ID: 23923969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-mediated rejection implies a poor prognosis in kidney transplantation: Results from a single center.
    Ciancio G; Gaynor JJ; Guerra G; Sageshima J; Roth D; Chen L; Kupin W; Mattiazzi A; Tueros L; Ruiz P; Vianna R; Burke GW
    Clin Transplant; 2018 Oct; 32(10):e13392. PubMed ID: 30152116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic microangiopathy in a renal allograft: Single-center five-year experience.
    Vanikar AV; Kanodia KV; Suthar KS; Nigam LA; Patel RD; Thakkar UG; Mehta AH
    Saudi J Kidney Dis Transpl; 2020; 31(6):1331-1343. PubMed ID: 33565445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo thrombotic microangiopathy after kidney transplantation in adults: Interplay between complement genetics and multiple endothelial injury.
    Dessaix K; Bontoux C; Aubert O; Grünenwald A; Sberro Soussan R; Zuber J; Duong Van Huyen JP; Anglicheau D; Legendre C; Fremeaux Bacchi V; Rabant M
    Am J Transplant; 2024 Jul; 24(7):1205-1217. PubMed ID: 38320731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Older kidney transplant patients experience less antibody-mediated rejection: a retrospective study of patients with mild to moderate sensitization.
    Scalea JR; Redfield RR; Muth BL; Mohamed M; Wilson NA; Ellis TM; Kaufman DB; Djamali A
    Clin Transplant; 2015 Dec; 29(12):1090-7. PubMed ID: 26361077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
    Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing transplant glomerulopathy in the absence of C4d deposition and donor-specific antibodies to chronic antibody-mediated rejection.
    Torres IB; Salcedo M; Moreso F; Sellarés J; Castellá E; Azancot MA; Perelló M; Cantarell C; Serón D
    Clin Transplant; 2014 Oct; 28(10):1148-54. PubMed ID: 25103874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.
    Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E
    Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
    Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Value of Protocol Biopsies to Identify Patients With De Novo Donor-Specific Antibody at High Risk for Allograft Loss.
    Schinstock CA; Cosio F; Cheungpasitporn W; Dadhania DM; Everly MJ; Samaniego-Picota MD; Cornell L; Stegall MD
    Am J Transplant; 2017 Jun; 17(6):1574-1584. PubMed ID: 27977905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presentation and Outcomes of C4d-Negative Antibody-Mediated Rejection After Kidney Transplantation.
    Orandi BJ; Alachkar N; Kraus ES; Naqvi F; Lonze BE; Lees L; Van Arendonk KJ; Wickliffe C; Bagnasco SM; Zachary AA; Segev DL; Montgomery RA
    Am J Transplant; 2016 Jan; 16(1):213-20. PubMed ID: 26317487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Relationship of the Severity and Category of Acute Rejection With Intimal Arteritis Defined in Banff Classification to Clinical Outcomes.
    Wu K; Budde K; Schmidt D; Neumayer HH; Rudolph B
    Transplantation; 2015 Aug; 99(8):e105-14. PubMed ID: 25719260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection.
    Satoskar AA; Pelletier R; Adams P; Nadasdy GM; Brodsky S; Pesavento T; Henry M; Nadasdy T
    Am J Transplant; 2010 Aug; 10(8):1804-11. PubMed ID: 20659088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic microangiopathy and peritubular capillary C4d expression in renal allograft biopsies.
    Meehan SM; Kremer J; Ali FN; Curley J; Marino S; Chang A; Kadambi PV
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):395-403. PubMed ID: 20966124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of tacrolimus-associated thrombotic microangiopathy after ABO-blood-type-incompatible renal transplantation.
    Takeda A; Ohtsuka Y; Horike K; Inaguma D; Goto N; Watarai Y; Uchida K; Morozumi K
    Clin Transplant; 2011 Jul; 25 Suppl 23():15-8. PubMed ID: 21623908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of progressive thrombotic microangiopathy after ABO-incompatible renal transplantation.
    Miura M; Fujita H; Suzuki A; Kubota KC; Fukasawa Y; Shimoda N; Tsuchihashi S; Tamaki T
    Clin Transplant; 2011 Jul; 25 Suppl 23():19-22. PubMed ID: 21623909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of transplant glomerulopathy and thrombotic microangiopathy in kidney transplant biopsies.
    Sreedharanunni S; Joshi K; Duggal R; Nada R; Minz M; Sakhuja V
    Transpl Int; 2014 Aug; 27(8):784-92. PubMed ID: 24684170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.